HomeCompareSCOTF vs JNJ

SCOTF vs JNJ: Dividend Comparison 2026

SCOTF yields 1.31% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCOTF wins by $19.1K in total portfolio value
10 years
SCOTF
SCOTF
● Live price
1.31%
Share price
$115.36
Annual div
$1.51
5Y div CAGR
45%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.4K
Annual income
$10,608.68
Full SCOTF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SCOTF vs JNJ

📍 SCOTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCOTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCOTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCOTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCOTF
Annual income on $10K today (after 15% tax)
$111.26/yr
After 10yr DRIP, annual income (after tax)
$9,017.38/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SCOTF beats the other by $5,031.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCOTF + JNJ for your $10,000?

SCOTF: 50%JNJ: 50%
100% JNJ50/50100% SCOTF
Portfolio after 10yr
$39.8K
Annual income
$7,649.04/yr
Blended yield
19.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCOTF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
7.2
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCOTF buys
0
JNJ buys
0
No recent congressional trades found for SCOTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCOTFJNJ
Forward yield1.31%2.13%
Annual dividend / share$1.51$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR45%28%
Portfolio after 10y$49.4K$30.3K
Annual income after 10y$10,608.68$4,689.40
Total dividends collected$26.5K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SCOTF vs JNJ ($10,000, DRIP)

YearSCOTF PortfolioSCOTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,890$189.80$10,592$272.30+$298.00SCOTF
2$11,932$280.09$11,289$357.73+$643.00SCOTF
3$13,183$415.89$12,123$472.89+$1.1KSCOTF
4$14,729$622.68$13,141$629.86+$1.6KSCOTF
5$16,703$942.75$14,408$846.81+$2.3KSCOTF
6$19,321$1,448.75$16,021$1,151.60+$3.3KSCOTF
7$22,944$2,270.98$18,122$1,588.22+$4.8KSCOTF
8$28,205$3,654.66$20,930$2,228.20+$7.3KSCOTF
9$36,267$6,088.14$24,792$3,191.91+$11.5KSCOTF
10$49,415$10,608.68$30,274$4,689.40+$19.1KSCOTF

SCOTF vs JNJ: Complete Analysis 2026

SCOTFStock

Scout24 SE operates ImmoScout24, a digital platform for the residential and commercial real estate sectors in Germany and internationally. The company offers Realtor Lead Engine and Immoverkauf24 products for selling real estate; Mortgage Lead Engine, a product to finance real estate; FLOWFACT and Propstack, a CRM software solution for real estate agents; and TenantPlus+ provides rental properties. In addition, BuyerPlus+ for users looking to buy properties; and Vermietet.de: a cloud-based software solution. The company was formerly known as Scout24 AG and changed its name to Scout24 SE in October 2021. Scout24 SE was founded in 1998 and is headquartered in Munich, Germany.

Full SCOTF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SCOTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCOTF vs SCHDSCOTF vs JEPISCOTF vs OSCOTF vs KOSCOTF vs MAINSCOTF vs ABBVSCOTF vs MRKSCOTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.